O'Shaughnessy Asset Management’s Indivior Pharmaceuticals INDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.06M Buy
171,948
+3,361
+2% +$122K 0.03% 466
2026
Q1
$5.14M Buy
168,587
+103
+0.1% +$3.4K 0.03% 516
2025
Q4
$6.05M Buy
168,484
+32,046
+23% +$978K 0.03% 464
2025
Q3
$3.29M Buy
136,438
+125,274
+1,122% +$2.62M 0.02% 630
2025
Q2
$165K Buy
+11,164
New +$130K ﹤0.01% 1876

Other funds holding INDV

O'Shaughnessy Asset Management's INDV Position: Q2 2026 in Review

O'Shaughnessy Asset Management increased its Indivior Pharmaceuticals (INDV) stake by 2% in Q2 2026, buying an estimated $122K and bringing the position to 171,948 shares worth $7.06M. The position accounts for 0.03% of the portfolio, ranked #466.

O'Shaughnessy Asset Management first reported a position in INDV in Q2 2025 and has held it in 5 quarters since. 338 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • O'Shaughnessy Asset Management held 171,948 shares of Indivior Pharmaceuticals worth $7.06M as of Q2 2026.
  • O'Shaughnessy Asset Management bought 3,361 Indivior Pharmaceuticals shares in Q2 2026, an estimated $122K.
  • Indivior Pharmaceuticals made up 0.03% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #466 holding.
  • O'Shaughnessy Asset Management first reported a position in Indivior Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
  • 338 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.